Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31070217 | 1.00 | CES2 (0.40) | CES2CES1 | |
| SCHEMBL1425995 | 0.87 | NOTUM (0.31) | — | |
| SCHEMBL29559941 | 0.87 | NOTUM (0.31) | — | |
| SCHEMBL45430 | 0.79 | CES2 (0.53) | CES2CES1 | |
| SCHEMBL29489580 | 0.79 | CES2 (0.53) | CES2CES1 | |
| SCHEMBL18709780 | 0.77 | NOTUM (0.43) | CES2CES1 | |
| Ammonia Solution, Strong SCHEMBL3047305 | 0.75 | CES2 (0.50) | CES2CES1 | |
| SCHEMBL11355080 | 0.75 | CES2 (0.50) | CES2CES1 | |
| SCHEMBL3975406 | 0.75 | CES2 (0.50) | CES2CES1 | |
| SCHEMBL23486898 | 0.75 | NOTUM (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119264026-A | Method for synthesizing cyclic sulfonamide and sulfonyl olefin by mechanical light excitation | 西北大学 | 2025-01-07 | — | — | CN | claimed |
| EP-1362860-B1 | Method for producing tetrakis (fluoraryl)borate magnesium compound | NIPPON CATALYTIC CHEM IND (JP) | 2010-09-15 | — | — | EP | claimed |
| US-7205441-B2 | Method for producing tetrakis (fluoroaryl) borate-magnesium compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2007-04-17 | — | — | US | claimed |
| US-20030216598-A1 | Method for producing tetrakis ( fluoroaryl) borate-magnesium compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2003-11-20 | — | — | US | claimed |
| EP-1362860-A1 | Method for producing tetrakis (fluoroaryl) borate magnesium compound | Nippon Shokubai Co., Ltd. (JP) | 2003-11-19 | — | — | EP | claimed |
| EP-3667751-B1 | PASSIVATION OF METAL HALIDE PEROVSKITES | UNIV OXFORD INNOVATION LTD (GB) | 2026-03-11 | — | — | EP | disclosed |
| US-12509987-B2 | Continuous characterization and communication of chemical tracer | Patina IP LLC (US) | 2025-12-30 | — | — | US | disclosed |
| US-12288825-B2 | Photovoltaic device comprising a metal halide perovskite and a passivating agent | OXFORD PHOTOVOLTAICS LIMITED (GB) | 2025-04-29 | — | — | US | disclosed |
| CN-119264026-A | Method for synthesizing cyclic sulfonamide and sulfonyl olefin by mechanical light excitation | 西北大学 | 2025-01-07 | — | — | CN | disclosed |
| WO-2024058815-A1 | CONTINUOUS CHARACTERIZATION AND COMMUNICATION OF CHEMICAL TRACER | Patina IP LLC (US) | 2024-03-21 | — | — | WO | disclosed |
| US-11799039-B2 | Photovoltaic device comprising a metal halide perovskite and a passivating agent | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2023-10-24 | — | — | US | disclosed |
| US-20230296018-A1 | CONTINUOUS CHARACTERIZATION AND COMMUNICATION OF CHEMICAL TRACER | Patina LLC (US) | 2023-09-21 | — | — | US | disclosed |
| US-6235222-B1 | REACTING, IN SOLVENT CONTAINING CHAIN ETHER SOLVENT, HYDROCARBON MAGNESIUM HALIDE WITH FLUOROARYL HALIDE | NIPPON SHOKUBAI CO., LTD. (JP) | 2001-05-22 | — | — | US | disclosed |
| EP-1061112-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2000-12-20 | — | — | EP | disclosed |
| EP-0995753-A2 | Method for manufacturing fluoroaryl magnesium halide | Nippon Shokubai Co., Ltd. (JP) | 2000-04-26 | — | — | EP | disclosed |
| CN-1146159-A | X-ray contrast compositions containing cellulose derivatives | NYCOMED IMAGING AS (NO) | 1997-03-26 | — | — | CN | disclosed |
| US-5213710-A | Benzene derivatives and a liquid-crystalline medium | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1993-05-25 | — | — | US | disclosed |
| EP-0109606-B1 | PROCESS FOR THE FORMYLATION OF ARYL HALIDES | BAYER AG (DE) | 1986-01-22 | — | — | EP | disclosed |
| US-4536344-A | USING A PHOSPINE OR PHOSPHITE | BAYER AKTIENGESELLSCHAFT (DE) | 1985-08-20 | — | — | US | disclosed |
| EP-0109606-A1 | Process for the formylation of aryl halides | BAYER AG (DE) | 1984-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216598-A1 | Method for producing tetrakis ( fluoroaryl) borate-magnesium compound | KRAS, MGAM, CA3 | CES2 3957/4885CES1 4605/4885 |
| US-12509987-B2 | Continuous characterization and communication of chemical tracer | EXOSC10, CD69, FABP3 | CES2 2569/4885CES1 3128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.